[FGF23 tumor induced osteomalacia with localization of neoplasm in the tympanic cavity].

Autor:	Ovchinnikov AY; Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia., Khon EM; Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia., Bakotina AV; Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia., Miroshnichenko NA; Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia., Gronskaia SA; National Medical Research Center for Endocrinology, Moscow, Russia., Belaya ZE; National Medical Research Center for Endocrinology, Moscow, Russia.
Jazyk:	ruština
Zdroj:	Vestnik otorinolaringologii [Vestn Otorinolaringol] 2023; Vol. 88 (6), pp. 91-96.
DOI:	10.17116/otorino20238806191
Abstrakt:	Tumor induced osteomalacia is a rare paraneoplastic syndrome caused by mesenchymal tumors that secrete fibroblast growth factor 23 (FGF23). Patients complain of progressive bone pain, muscle weakness and brittle fractures. Delayed diagnosis of osteomalacia caused by a tumor is often found in clinical practice. When verifying the exact localization of the neoplasm, radical removal within healthy tissues is recommended. The article considers a clinical example of FGF23 tumor induced osteomalacia with localization of neoplasm in the tympanic cavity.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu